Premium
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Law Offices of Howard G. Smith announces that it is investigating whether Allion Healthcare, Inc.'s ("Allion" or the "Company") (NASDAQ: ALLI) directors complied with their...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Allion Healthcare, Inc. (“Allion” or the “Company”...
Attorney Advertising. Notice is hereby given that Stull, Stull & Brody has commenced an investigation on behalf of shareholders of Allion Healthcare, Inc. (“Allion” or the...
Attorney Advertising. The law firm of Wolf Haldenstein Adler Freeman & Herz LLP is investigating possible breaches of fiduciary duty by the Board of Directors of Allion...
Levi & Korsinsky is investigating the Board of Directors of Allion Healthcare, Inc. (“Allion” or the “Company”) (NasdaqGM: ALLI) for possible breaches of fiduciary duty and...
Allion Healthcare, Inc. (NASDAQ: ALLI) today announced that it has entered into a definitive merger agreement for the Company to be acquired and taken private by an affiliate of...
Allion Healthcare (NASDAQ: ALLI): Second Quarter Highlights Net sales increased 15.3% to $100 million from $86 million Specialty HIV net sales increased 9.4% to $75...
Allion Healthcare, Inc. (NASDAQ: ALLI), today announced that it has entered into a partnership with Being Alive San Diego to launch a Community Learning Center in San Diego...
Allion Healthcare, Inc. (NASDAQ: ALLI), today announced that it will release its financial results for the second quarter ended June 30, 2009, after the close of U.S. financial...
Allion Healthcare (NASDAQ: ALLI): Fully Diluted EPS Guidance increased to $0.50 to $ 0.52 per share Net sales increased 48% to $96.6 million from $65.3 million Net...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
